Short Interest in AquaBounty Technologies, Inc. (NASDAQ:AQB) Grows By 109.3%

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the target of a large growth in short interest in the month of August. As of August 14th, there was short interest totaling 183,426 shares, a growth of 109.3% from the July 30th total of 87,636 shares. Currently, 3.6% of the shares of the stock are sold short. Based on an average trading volume of 2,836,488 shares, the short-interest ratio is currently 0.1 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the business. Renaissance Technologies LLC lifted its holdings in shares of AquaBounty Technologies by 311.9% in the 4th quarter. Renaissance Technologies LLC now owns 121,585 shares of the company’s stock worth $113,000 after acquiring an additional 92,065 shares during the last quarter. Two Sigma Investments LP purchased a new stake in shares of AquaBounty Technologies in the 3rd quarter valued at $84,000. Finally, BlackRock Inc. bought a new position in shares of AquaBounty Technologies during the 2nd quarter valued at $51,000. 8.92% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised shares of AquaBounty Technologies from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, August 12th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the company presently has a consensus rating of “Sell”.

AquaBounty Technologies Stock Performance

AQB traded down $0.06 during trading on Friday, reaching $1.25. The stock had a trading volume of 41,991 shares, compared to its average volume of 1,470,088. The business has a 50-day moving average of $1.10 and a 200-day moving average of $1.00. AquaBounty Technologies has a one year low of $0.77 and a one year high of $2.95. The stock has a market cap of $6.43 million, a PE ratio of -1.52 and a beta of 1.39.

AquaBounty Technologies (NASDAQ:AQB) last issued its quarterly earnings results on Thursday, August 6th. The company reported ($0.26) earnings per share (EPS) for the quarter.

About AquaBounty Technologies

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.